Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors D Gladman, W Rigby, VF Azevedo, F Behrens, R Blanco, A Kaszuba, ... New England Journal of Medicine 377 (16), 1525-1536, 2017 | 532 | 2017 |
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) PS Helliwell, O FitzGerald, J Fransen, DD Gladman, GG Kreuger, ... Annals of the rheumatic diseases 72 (6), 986-991, 2013 | 337 | 2013 |
Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 248 | 2019 |
Occurrence of fibromyalgia in patients with ankylosing spondylitis VF Azevedo, ES Paiva, LRH Felippe, RA Moreira Revista brasileira de reumatologia 50, 646-650, 2010 | 122 | 2010 |
Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 115 | 2019 |
Benzbromarone in the treatment of gout VF Azevedo, IA Kos, AB Vargas-Santos, GRC Pinheiro, ES Paiva Advances in Rheumatology 59, 37, 2019 | 109 | 2019 |
Switching between reference biologics and biosimilars for the treatment of rheumatology, gastroenterology, and dermatology inflammatory conditions: considerations for the clinician R Moots, V Azevedo, JL Coindreau, T Dörner, E Mahgoub, E Mysler, ... Current rheumatology reports 19, 1-16, 2017 | 108 | 2017 |
Fenebrutinib versus placebo or Adalimumab in rheumatoid arthritis: A randomized, Double‐Blind, phase II trial S Cohen, K Tuckwell, TR Katsumoto, R Zhao, J Galanter, C Lee, J Rae, ... Arthritis & Rheumatology 72 (9), 1435-1446, 2020 | 104 | 2020 |
Gender characterization in a large series of Brazilian patients with spondyloarthritis HMS de Carvalho, AB Bortoluzzo, CR Gonçalves, JAB da Silva, ... Clinical rheumatology 31, 687-695, 2012 | 92 | 2012 |
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry CDL Marques, AM Kakehasi, MM Pinheiro, LMH Mota, CP Albuquerque, ... RMD open 7 (1), e001461, 2021 | 78 | 2021 |
Consenso Brasileiro de Espondiloartropatias: espondilite anquilosante e artrite psoriásica diagnóstico e tratamento-Primeira Revisão PD Sampaio-Barros, VF Azevedo, R Bonfiglioli, WR Campos, ... Revista Brasileira de Reumatologia 47, 233-242, 2007 | 75 | 2007 |
Etanercept biosimilars VF Azevedo, N Galli, A Kleinfelder, J D’Ippolito, PCM Urbano Rheumatology international 35, 197-209, 2015 | 74 | 2015 |
Allopurinol, benzbromarone, or a combination in treating patients with gout: analysis of a series of outpatients VF Azevedo, PG Buiar, LH Giovanella, CR Severo, M Carvalho International Journal of Rheumatology 2014 (1), 263720, 2014 | 71 | 2014 |
Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies G Castañeda-Hernández, Z Szekanecz, E Mysler, VF Azevedo, ... Joint Bone Spine 81 (6), 471-477, 2014 | 67 | 2014 |
Potential regulatory and commercial environment for biosimilars in Latin America VF Azevedo, E Sandorff, B Siemak, RJ Halbert Value in health regional issues 1 (2), 228-234, 2012 | 55 | 2012 |
Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. TL Skare, N Leite, AB Bortoluzzo, CR Gonçalves, JA Da Silva, ... Clinical and experimental rheumatology 30 (3), 351-357, 2012 | 54 | 2012 |
Rituximab-induced regression of CREST-related calcinosis DR de Paula, FB Klem, PG Lorencetti, C Muller, VF Azevedo Clinical rheumatology 32, 281-283, 2013 | 51 | 2013 |
Recommendations for the regulation of biosimilars and their implementation in Latin America AA Álvarez, E Mysler, EM Ruiz de Castilla, FJ Flores-Murrieta, J Hughes, ... GaBI J 3, 143-148, 2014 | 50 | 2014 |
Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis S Carneiro, A Bortoluzzo, C Gonçalves, JAB da Silva, AC Ximenes, ... The Journal of Rheumatology 40 (10), 1719-1725, 2013 | 47 | 2013 |
Biosimilar-to-biosimilar switching: what is the rationale and current experience? E Mysler, VF Azevedo, S Danese, D Alvarez, N Iikuni, B Ingram, M Mueller, ... Drugs 81 (16), 1859-1879, 2021 | 46 | 2021 |